Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022
Mark W. Tenforde, Manish M. Patel, Nathaniel M. Lewis, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 6, pp. 1030-1037
Open Access | Times Cited: 16

Showing 16 citing articles:

Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024
Xinchun Gu, Conall Watson, Utkarsh Agrawal, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e52047-e52047
Open Access | Times Cited: 5
Soluble influenza H3 trimer proteins enhance the breadth and potency of antibody response
Cuicui Liu, Yan-Xia Ru, Hui-ru Li, et al.
International Journal of Biological Macromolecules (2025), pp. 142240-142240
Closed Access
Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023
Nathaniel M. Lewis, Yuwei Zhu, Ithan D. Peltan, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 4, pp. 1056-1064
Open Access | Times Cited: 15
Influenza vaccine effectiveness against influenza A during the delayed 2022/23 epidemic in Shihezi, China
Yinxia Su, Zihao Guo, Xiu Gu, et al.
Vaccine (2023) Vol. 41, Iss. 39, pp. 5683-5686
Closed Access | Times Cited: 12
Influenza Vaccine Effectiveness Against Influenza A–Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022–2023
Mark W. Tenforde, Zachary A. Weber, Duck‐Hye Yang, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 1, pp. 141-151
Open Access | Times Cited: 12
Real-world effectiveness of influenza vaccine against medical-attended influenza infection during 2023/24 season in Ili Kazakh Autonomous Prefecture, China: A test-negative, case-control study
Jia Mi, Juping Wang, Luping Chen, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design
Amanda B. Payne, Allison Avrich Ciesla, Elizabeth Rowley, et al.
Vaccine (2023) Vol. 41, Iss. 51, pp. 7581-7586
Closed Access | Times Cited: 5
Targeting H3N2 Influenza: Advancements in Treatment and Vaccine Strategies
Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, et al.
(2024)
Open Access | Times Cited: 1
Assessment and mitigation of bias in influenza and COVID-19 vaccine effectiveness analyses — IVY Network, September 1, 2022–March 30, 2023
Nathaniel M. Lewis, Elizabeth Harker, Aleda M. Leis, et al.
Vaccine (2024) Vol. 43, pp. 126492-126492
Closed Access | Times Cited: 1
Estimated Effectiveness of Influenza Vaccines in Preventing Secondary Infections in Households
Carlos G. Grijalva, Huong Q. Nguyen, Yuwei Zhu, et al.
JAMA Network Open (2024) Vol. 7, Iss. 11, pp. e2446814-e2446814
Open Access | Times Cited: 1
Targeting H3N2 influenza: advancements in treatment and vaccine strategies
Shriyansh Srivastava, Nandani Jayaswal, Sachin Kumar, et al.
Expert Review of Anti-infective Therapy (2024)
Closed Access | Times Cited: 1
A rapid and flexible microneutralization assay for serological assessment of influenza viruses
Kalee E. Rumfelt, William J. Fitzsimmons, Rachel Truscon, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 4
Open Access | Times Cited: 3
Bias in control selection associated with the use of rapid tests in influenza vaccine effectiveness studies
Eero Poukka, Caitriona Murphy, Loretta Mak, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022
Ashish C. Shrestha, Emma Field, Dharshi Thangarajah, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 9
Open Access
Risk factors for infection with influenza A(H3N2) virus on a US university campus, October–November 2021
Nathaniel M. Lewis, Miranda J. Delahoy, Kelsey M. Sumner, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 5
Open Access | Times Cited: 1
Postpandemic Sentinel Surveillance of Respiratory Diseases in the Context of the World Health Organization Mosaic Framework: Protocol for a Development and Evaluation Study Involving the English Primary Care Network 2023-2024 (Preprint)
Xinchun Gu, Conall Watson, Utkarsh Agrawal, et al.
(2023)
Closed Access | Times Cited: 1
A rapid and flexible microneutralization assay for serological assessment of influenza viruses
Kalee E. Rumfelt, William J. Fitzsimmons, Rachel Truscon, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top